908 Devices Q3 2026 net loss narrows 69% to $4.58 million; Q3 2026 revenue rises 35% to $18.95 million
- 908 Devices’ third-quarter 2026 net loss from continuing operations narrowed 69% year-over-year to $4.58 million.
- Revenue climbed 35% year-over-year to $19 million, driven by higher FTIR product revenue and the addition of NIRLab.
- Device placements reached a record 308, while the installed base grew 26% year-over-year to 4,409.
- Full-year 2026 revenue guidance rose at the low end to $68.5 million–$70 million, representing 22%–25% growth over 2025.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 908 Devices Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261110020682) on November 10, 2026, and is solely responsible for the information contained therein.